PDPN and neoplasm: In the present study, we establish that inhibition of PDPN using the CY12-RP2 inhibitory peptide attenuates melanoma progression in multiple murine models, concomitant with reduced functional exhaustion of tumor-infiltrating CD8+ T cells.